Get started
Author

Joseph Chan

An Uncontrolled Pilot Study of Ht7 for ‘stress’
2002 · Joseph Chan, Dianne Briscomb, et al. · Acupuncture in Medicine · 29
Critical Event Debriefing in a Community Hospital
2020 · Chidiebere V Ugwu, Marsha Medows, et al. · Cureus · 19
PDF
Radiation oncology patients’ perceptions of artificial intelligence and machine learning in cancer care: A multi-centre cross-sectional study
2025 · Joseph Chan, Lisa Parker, et al. · Radiotherapy and Oncology · 10
Magic for Mastalgia with Ht7
2014 · Joseph Chan · Acupuncture in Medicine · 4
Functional Characterisation of the ATOH1 Molecular Subtype Indicates a Pro-Metastatic Role in Small Cell Lung Cancer
2024 · Alessia Catozzi, Maria Peiris-Pagès, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 3
PDF
Transcatheter Treatment of Native Coarctation of the Aorta in a Child Using a Balloon-Expandable Endoprosthesis
2023 · Liwei Yu, Joseph Chan, et al. · JACC Case Reports · 2
Data from Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer
2023 · Adam J. Schoenfeld, Joseph M. Chan, et al. · 1
Complications and Utility of Gastrointestinal Endoscopy Post Hematopoietic Stem Cell Transplantation
2023 · Joseph Chan, Vasiliki Ganosi, et al. · Journal of Pediatric Gastroenterology and Nutrition · 1
Reply to Ci Jiwei
2015 · Joseph Chan · Dao · 1
Staged transcatheter therapy of coarctation of the aorta in children utilizing balloon-expandable covered stent grafts
2023 · Liwei Yu, Allison K. Cabalka, et al. · Progress in Pediatric Cardiology
Data from Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation
2023 · Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, et al.
Data from Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation
2023 · Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, et al.
Supplementary Figures from Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation
2023 · Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, et al.
Supplementary Tables from Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation
2023 · Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, et al.
Supplementary Tables from Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation
2023 · Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, et al.
Supplementary Figures from Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation
2023 · Alvaro Quintanal-Villalonga, Hirokazu Taniguchi, et al.
PDF
Supplemental Figure 1 from Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer
2023 · Adam J. Schoenfeld, Joseph M. Chan, et al.
Supplementary Methods from Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer
2023 · Adam J. Schoenfeld, Joseph M. Chan, et al.
Supplementary Table 2 from Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer
2023 · Adam J. Schoenfeld, Joseph M. Chan, et al.
Supplementary Figure Legend from Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer
2023 · Adam J. Schoenfeld, Joseph M. Chan, et al.
Supplemental Figure 2 from Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer
2023 · Adam J. Schoenfeld, Joseph M. Chan, et al.
Supplemental Table 1 from Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer
2023 · Adam J. Schoenfeld, Joseph M. Chan, et al.
Supplemental Figure 1 from Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer
2023 · Adam J. Schoenfeld, Joseph M. Chan, et al.
PDF
Supplemental Figure 2 from Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer
2023 · Adam J. Schoenfeld, Joseph M. Chan, et al.
PDF
Supplementary Methods from Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in EGFR-Mutant Lung Cancer
2023 · Adam J. Schoenfeld, Joseph M. Chan, et al.
Works count: 47
Citation count: 70
H-index: 4
I10-index: 3
Year
Topic
Type